U.S. employers advertised more jobs in June compared with the previous month, but overall hiring fell, painting a mixed picture of the job market.

The number of jobs posted on the last day in June jumped 9.6% to 5.9 million, the Labor Department said Monday, a solid gain but still below the pre-pandemic level of about 7 million. And employers hired 6.7 million people in June, down from 7.2 million in May, a record high.

The figures, included in the government’s Job Openings and Labor Turnover survey, or JOLTS, provide a more detailed snapshot of the job market than the monthly employment report. It reports on job openings as well as the gross number of hires and the number of people quitting their jobs. The monthly jobs figures cover net gains or losses.

On Friday, the government said that employers added 1.8 million jobs in July, the third month of solid gains, but much lower than June’s 4.8 million and May gains of 2.7 million.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tesla is a meme as global economy is fueled by collective delusion – Max Keiser

“It’s all cosmetic, it’s all perception,” it senses 1971 going off the gold standard, says Max, adding that “The valuation is driven by perception. Tesla is a meme, that’s the value, it’s the perception of the meme.” According to him,…

JPMorgan picked as adviser for sale of stake in $7.3 billion Turkish motorway: sources

LONDON/ISTANBUL (Reuters) – JPMorgan (JPM.N) has been picked as an adviser for the sale of a stake in a $7.3 billion motorway in Turkey, four sources familiar with the matter said. Billed as a landmark project in the financing of…

Wall Street tumbles at open on fear over fresh virus cases

(Reuters) – U.S. stocks opened sharply lower on Monday as a resurgence in new coronavirus cases in China and parts of the United States dampened hopes of a swift economic revival that drove the Nasdaq to record highs last week.…

How Moderna execs are cashing in on COVID-19 vaccine stock speculation

(Reuters) – Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the…